TP53 and prostate cancer: Co-culturing fibroblasts with prostate cancer cells inhibits the expression of P53 via transferring exosomal miR-27a to the recipient cells and downregulation of P53 is linked with increased resistance to cisplatin, doxorubicin, and docetaxel [102].